Journal Title：Journal Of Cancer Survivorship

Cancer survivorship is a worldwide concern. The aim of this multidisciplinary journal is to provide a global forum for new knowledge related to cancer survivorship. The journal publishes peer-reviewed papers relevant to improving the understanding, prevention, and management of the multiple areas related to cancer survivorship that can affect quality of care, access to care, longevity, and quality of life. It is a forum for research on humans (both laboratory and clinical), clinical studies, systematic and meta-analytic literature reviews, policy studies, and in rare situations case studies as long as they provide a new observation that should be followed up on to improve outcomes related to cancer survivors. Published articles represent a broad range of fields including oncology, primary care, physical medicine and rehabilitation, many other medical and nursing specialties, nursing, health services research, physical and occupational therapy, public health, behavioral medicine, psychology, social work, evidence-based policy, health economics, biobehavioral mechanisms, and qualitative analyses. The journal focuses exclusively on adult cancer survivors, young adult cancer survivors, and childhood cancer survivors who are young adults. Submissions must target those diagnosed with and treated for cancer.

癌癥幸存者是一個全球性問題。這本多學(xué)科期刊的目的是為癌癥幸存者的新知識提供一個全球論壇。該期刊發(fā)表同行評審的論文，旨在提高對癌癥幸存者相關(guān)多個領(lǐng)域的理解、預(yù)防和管理，這些領(lǐng)域可能影響護(hù)理質(zhì)量、獲得護(hù)理的機會、壽命和生活質(zhì)量。它是一個人類研究（實驗室和臨床）、臨床研究、系統(tǒng)和薈萃分析文獻(xiàn)綜述、政策研究以及在極少數(shù)情況下的案例研究的論壇，只要它們提供了新的觀察結(jié)果，就應(yīng)該跟進(jìn)以改善與癌癥幸存者相關(guān)的結(jié)果。發(fā)表的文章代表了廣泛的領(lǐng)域，包括腫瘤學(xué)、初級保健、物理醫(yī)學(xué)和康復(fù)、許多其他醫(yī)學(xué)和護(hù)理專業(yè)、護(hù)理、衛(wèi)生服務(wù)研究、物理和職業(yè)治療、公共衛(wèi)生、行為醫(yī)學(xué)、心理學(xué)、社會工作、循證政策、衛(wèi)生經(jīng)濟學(xué)、生物行為機制和定性分析。該期刊專注于成年癌癥幸存者、青年癌癥幸存者和青年兒童癌癥幸存者。提交的作品必須針對那些被診斷患有癌癥并接受治療的人。

Journal Of Cancer Survivorship創(chuàng)刊于2007年，由Springer US出版商出版，收稿方向涵蓋ONCOLOGY全領(lǐng)域，此刊是該細(xì)分領(lǐng)域中屬于非常不錯的SCI期刊，在行業(yè)細(xì)分領(lǐng)域中學(xué)術(shù)影響力較大，專業(yè)度認(rèn)可很高，所以對原創(chuàng)文章要求創(chuàng)新性較高，如果您的文章質(zhì)量很高，可以嘗試。平均審稿速度 12周，或約稿 ，影響因子指數(shù)3.1，該期刊近期沒有被列入國際期刊預(yù)警名單，廣大學(xué)者值得一試。